Tom Martin

[Tom Martin @myelomatom]

Congratulations to Shaji, ECG-ACRIN and everyone involved - very important trial. However, since there wasn’t a clearly superior arm, the debate of RVd vs. KRD will persist. It actually opens the door for us to use either regimen based on “beliefs”.

[mSMART Myeloma @Myeloma_mSMART]

ENURANCE Phase III trial KRd vs VRd finds no clinical benefit but added toxicity with KRd. Trial lead by @myelomaMD. Plenary presentation at #ASCO20. @eaonc @mayoclinic @vincentrk https://t.co/ATGkRl2Exm

[Tom Martin @myelomatom]

The BCMA bispecific data are encouraging and if PFS approaches the 11-12 month mark - these OTS products would be preferred in triple class refractory. However, we still have other bispecific against others targets that may be better + hopefully we are all looking at biomarkers

[Sandy Wong @SandyWong02111]

Exciting results of teclistamab by @szusmani! 👍 ORR 67% in heavily pretx MM pt with long DoR even at low doses. 🙏 @myelomatom for 👍 discussion. AMG420 ORR 70%, CC93269 89% Need more data re: effectiveness of another BCMA directed tx once pt progresses through their first one.

[Tom Martin @myelomatom]

Really promising data from DrUsmani presented at ASCO Immunotherapy special session: Teclistamab ORD 67% in those treated at 270ug - with swimmers plot showing prelim durability

[Saad Z. Usmani MD MBA FASCO 🇺🇸🇵🇰 @szusmani]

Fantastic overview from @TomBmt133 @UCSFCancer on BCMA directed therapies in development #mmsm #ASCO2020 @ASCO — @ninashah33 what do you think?

[Saad Z. Usmani MD MBA FASCO 🇺🇸🇵🇰 @szusmani]

Fantastic overview from @TomBmt133 @UCSFCancer on BCMA directed therapies in development #mmsm #ASCO2020 @ASCO — @ninashah33 what do you think?

[Tom Martin @myelomatom]

ISA +K is very well tolerated and active! These results led to the IKEMA trial - expecting results soon!

[Tom Martin @myelomatom]

Interesting graph and the next 4-8 weeks will be very telling! Stay tuned stay masked

[Tom Martin @myelomatom]

I think California and our contingency may rival and surpass the south, come west everyone !!

[Sagar Lonial MD @SagarLonialMD]

When will you all realize that the people and weather are much nicer down south....

[Tom Martin @myelomatom]

Thank you to all the UVSF Nurses and nurses everywhere for doing all you do. Not a day passed that a patient doesn’t stop me to say how wonderful the nurses are!!!

[Stephen Colbert @StephenAtHome]

On this #NationalNursesDay, let’s thank all of the hero nurses who work on the frontlines and/or let kids fake stomach aches to get out of gym class.

[Tom Martin @myelomatom]

Worth a view for anyone interested in front-line perspective

[Bob Wachter @Bob_Wachter]

1/ Covid (@UCSF) Chronicles, Day 44

Thursday, so it’s Grand Rounds day: https://t.co/Z4JMKGPC9I @YouTube. I hope you’ll watch whole 100 min: clinical updates, contact tracing, & experience in NYC. If you can spare just 35 min, watch NYC part (@ 1:04:37): fascinating & poignant.

[Bob Wachter @Bob_Wachter]

1/ Covid (@UCSF) Chronicles, Day 38

Still stable at @UCSFHospitals & in SF. @UCSF, 15 pts, 5 on ventilators (Fig on L). In SF: 38 new cases, 23 deaths overall (up 1)(Fig R). A sad milestone: we passed 50,000 deaths in the U.S. today. Staggering, & tens of thousands more to come.

[Tom Martin @myelomatom]

@drjohnm Mandrola - what part of the world (besides your own) do you live in - youngster

[John Mandrola, MD @drjohnm]

Though we don't know how many of the asymptomatic will develop symptoms this is quite a remarkable observation (obviously I am late, just a day, but in #COVID19 time, a day is like a month)

[Tom Martin @myelomatom]

Dr Rutherford presenting at UCSF Town Hall

[Tom Martin @myelomatom]

Dr Rutherford at UZcSF updates benefits of shelter in place in Bay Are- keep it up everyone

[Tom Martin @myelomatom]

Shelter in place looking helpful in SF as Covid cases remain low.

[Tom Martin @myelomatom]

https://t.co/xZfhkbpxmE https://t.co/YwUA5D7uUK